News

News
In the media

The Startup Slam at BIO-Europe 2017! Choosing the Winner was Hard!

Read full story
Partner news

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story
Partner news

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story
Partner news

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story
In the media

Exec Chat: JNJ's Innovation Partnering Strategy Goes Broad And Beyond 'Pinpoint Intervention'

Read full story
Partner news

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story
Partner news

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story
In the media

Breaking down barriers – the best way to positively impact everybody’s health

Read full story
In the media

Breaking down barriers – the best way to positively impact everybody’s health

Read full story
Partner news

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story
Partner news

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story
Partner news

Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease

Read full story
In the media

Scientists meet the media: ‘Important we tell stories about science’s boundless frontier’

Read full story
Partner news

Aelix Therapeutics appoints HIV expert as CMO

Read full story
Partner news

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Read full story